These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 36614268)

  • 21. Antibody-Drug Conjugates-A Tutorial Review.
    Baah S; Laws M; Rahman KM
    Molecules; 2021 May; 26(10):. PubMed ID: 34063364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody-Drug Conjugates-Evolution and Perspectives.
    Chis AA; Dobrea CM; Arseniu AM; Frum A; Rus LL; Cormos G; Georgescu C; Morgovan C; Butuca A; Gligor FG; Vonica-Tincu AL
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of Peptide-Drug Conjugates for Selective Targeting of Malignant Tumor Cells.
    Vrettos EI; Tzakos AG
    Methods Mol Biol; 2021; 2207():327-338. PubMed ID: 33113145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive review on the elaboration of payloads derived from natural products for antibody-drug conjugates.
    Lu N; Wu J; Tian M; Zhang S; Li Z; Shi L
    Eur J Med Chem; 2024 Mar; 268():116233. PubMed ID: 38408390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential.
    Ceci C; Lacal PM; Graziani G
    Pharmacol Ther; 2022 Aug; 236():108106. PubMed ID: 34990642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assembly of pH-Responsive Antibody-Drug-Inspired Conjugates.
    Raabe M; Heck AJ; Führer S; Schauenburg D; Pieszka M; Wang T; Zegota MM; Nuhn L; Ng DYW; Kuan SL; Weil T
    Macromol Biosci; 2022 Feb; 22(2):e2100299. PubMed ID: 34791790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Technologies Bloom Together for Bettering Cancer Drug Conjugates.
    Jin Y; Edalatian Zakeri S; Bahal R; Wiemer AJ
    Pharmacol Rev; 2022 Jul; 74(3):680-711. PubMed ID: 35710136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody Drug Conjugates for Cancer Therapy: From Metallodrugs to Nature-Inspired Payloads.
    Tonon G; Rizzolio F; Visentin F; Scattolin T
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advances in targeted therapy for pancreatic cancer.
    Xing L; Lv L; Ren J; Yu H; Zhao X; Kong X; Xiang H; Tao X; Dong D
    Biomed Pharmacother; 2023 Dec; 168():115717. PubMed ID: 37862965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody-Drug Conjugates for Cancer Therapy.
    Hafeez U; Parakh S; Gan HK; Scott AM
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33081383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry.
    Hong Y; Nam SM; Moon A
    Arch Pharm Res; 2023 Mar; 46(3):131-148. PubMed ID: 36877356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-drug conjugates for targeted cancer therapy: Recent advances in potential payloads.
    Xi M; Zhu J; Zhang F; Shen H; Chen J; Xiao Z; Huangfu Y; Wu C; Sun H; Xia G
    Eur J Med Chem; 2024 Oct; 276():116709. PubMed ID: 39068862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody-drug conjugates: an emerging modality for the treatment of cancer.
    Leal M; Sapra P; Hurvitz SA; Senter P; Wahl A; Schutten M; Shah DK; Haddish-Berhane N; Kabbarah O
    Ann N Y Acad Sci; 2014 Aug; 1321():41-54. PubMed ID: 25123209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody-Drug Conjugates: A promising breakthrough in cancer therapy.
    Parit S; Manchare A; Gholap AD; Mundhe P; Hatvate N; Rojekar S; Patravale V
    Int J Pharm; 2024 Jun; 659():124211. PubMed ID: 38750981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel formats of antibody conjugates: recent advances in payload diversity, conjugation, and linker chemistry.
    Fujii T; Matsuda Y
    Expert Opin Biol Ther; 2023; 23(11):1053-1065. PubMed ID: 37953519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linkers Having a Crucial Role in Antibody-Drug Conjugates.
    Lu J; Jiang F; Lu A; Zhang G
    Int J Mol Sci; 2016 Apr; 17(4):561. PubMed ID: 27089329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities.
    Maiti R; Patel B; Patel N; Patel M; Patel A; Dhanesha N
    Arch Pharm Res; 2023 May; 46(5):361-388. PubMed ID: 37071273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody-Assisted Delivery of a Peptide-Drug Conjugate for Targeted Cancer Therapy.
    Kim H; Hwang D; Choi M; Lee S; Kang S; Lee Y; Kim S; Chung J; Jon S
    Mol Pharm; 2019 Jan; 16(1):165-172. PubMed ID: 30521347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody drug conjugates beyond cytotoxic payloads.
    Hobson AD
    Prog Med Chem; 2023; 62():1-59. PubMed ID: 37981349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-drug conjugates: Promising and efficient tools for targeted cancer therapy.
    Nasiri H; Valedkarimi Z; Aghebati-Maleki L; Majidi J
    J Cell Physiol; 2018 Sep; 233(9):6441-6457. PubMed ID: 29319167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.